Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
Clinical trial NCT02405221 · COMPLETED
Trial details
- NCT number
- NCT02405221
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-04
- Primary completion
- 2024-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.